VICODIN HP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vicodin Hp, and what generic alternatives are available?
Vicodin Hp is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in VICODIN HP is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Summary for VICODIN HP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 37 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VICODIN HP at DailyMed |
Recent Clinical Trials for VICODIN HP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Weill Medical College of Cornell University | Phase 4 |
| Boston University | Phase 4 |
| Antonios Likourezos | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for VICODIN HP
US Patents and Regulatory Information for VICODIN HP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | VICODIN HP | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040117-001 | Sep 23, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
